[AISWorld] [Call for Papers] Innovating for Competitive & Successful Clinical Trials

[Cutter, an Arthur D. Little community]

 Get published in Amplify!
https://www.cutter.com/call-papers

Image: 
To see the original, click here:
https://experts.cutter.com/acton/ct/19169/s-1826-2407/Bct/l-5ec1/l-5ec1:2d0/ct4_0/1/lip?sid=TV2%3AoeSrlmc55
Target URL: https://www.cutter.com/call-papers#clinicaltrials
 
Competition among clinical trials that target the same diseases and 
patient groups has ramped up the complexity of achieving trial success 
and regulatory approval while prioritizing patient needs.

For an upcoming issue of Amplify with Guest Editors Ulrica Sehlstedt, 
Ben Enejo, and Franziska Thomas of Arthur D. Little, we seek articles 
exploring innovative strategies and approaches to expedite and 
streamline clinical trials, improve patient centricity and drive 
successful outcomes.

Get more information or submit a proposal!

https://www.cutter.com/call-papers#clinicaltrials

Possible article ideas include (but are not limited to) the following:

What is the future of clinical trials and what criteria are required to 
"win"?

How can drug developers cultivate capabilities today to avoid going 
extinct tomorrow?

Given the lack of mastery, does the rapid expanse of technological 
advances offer "real" innovation and competitiveness?

What measures can be taken by drug developers to reduce unnecessary 
complexity in clinical trials?

What innovative approaches can drive true patient centricity in clinical 
trials and treatments of the future?

How can the experience of patients, investigators and trial centers be 
improved to ensure more effective recruitment and treatment of patients?

What are the risks of leveraging AI to accelerate trial cycles and 
patient outcomes?

How should data privacy frameworks be adapted to fit future clinical 
trial needs while protecting patient confidentiality?

What innovative strategies can accelerate the registration pathway for 
new therapies?

FOR CONSIDERATION: Please send an abstract (~300 words or less of 
proposed article scope and author(s) bio) to Ulrica Sehlstedt, Ben 
Enejo, Franziska Thomas and Christine Generali . Final article length is 
2,000-3,500 words plus graphics. More editorial guidelines

https://www.cutter.com/call-papers#Editorial%20Guidelines

.

Get more information or submit a proposal!

https://www.cutter.com/call-papers#clinicaltrials

WHY PUBLISH IN AMPLIFY?

Increase the visibility and promotion of your work

Reach a global audience of business leaders, technologists and academics

Work with experienced editors providing valuable feedback for article 
improvement

Showcase your work quicker with our efficient publishing cycle & 
turnaround times

Share your published article immediately (social media, academic 
research bases)

Monthly, Amplify

https://www.cutter.com/journals/amplify

spotlights key business themes: leadership, technology, industry, and 
sustainability. Our global network of experts, including thought 
leaders, strategists, technologists, and academics, share innovative 
ideas, research, case studies, and opinions on crucial business and 
technology issues.

For questions, please contact Christine Generali , Amplify Publisher.

We look forward to working with you!

--------------------------------------------------------------------------------
Copyright © 2024 Arthur D. Little | Cutter, an Arthur D. Little community | 10 High Street, Suite 900, Boston, MA 02110, USA | Manage your email preferences
https://experts.cutter.com/acton/rif/19169/s-1826-2407/-/l-5ec1:2d0/l-5ec1/zout?sid=TV2%3AoeSrlmc55